We mined CB Insights valuation data to reveal how AI, geographic concentration, and secondary markets are shaping today's most valuable private companies.
We dive into the data on high-momentum, private generative AI companies in drug discovery, including key financial metrics, opportunities, and threats.
Using the CB Insights Business Graph, we analyzed 1,140+ early-stage deals in August to identify the most promising companies, top investors, and emerging categories to watch.
We dive into the data on companies with AI agents and copilots servicing the industrial sector, including key financial metrics, opportunities, and threats.
CB Insights deal and partnership data shows the largest payments firms are consolidating SMB financial services and shaping the next era of SMB relationships.
CB Insights' emerging technology insights platform provides all the analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech.
